ARTICLE | Clinical News
PH80 nasally administered vomeropherin compound: Phase I
October 19, 1998 7:00 AM UTC
Pherin Pharmaceuticals Inc., Menlo Park, Calif. Product: PH80 nasally administered vomeropherin compound Indication: Treat premenstrual syndrome (PMS) Status: Pherin and partner N.V. Organon will beg...